Tango Therapeutics, Inc. (TNGX) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 0 | 0 | 53.81M | 3.18M | 5.39M | 4.12M | 11.61M | 19.88M | 6.47M | 5.43M | 10.73M | 14.6M | 5.77M | 6.41M | 6.92M | 5.77M | 5.76M | 5.72M | 6.79M | 18.15M |
| Revenue Growth % | -100% | -100% | 363.61% | -84% | -16.67% | -24.19% | 8.15% | 36.15% | 12.23% | -15.29% | 55.09% | 152.95% | 0.14% | 12.16% | 1.96% | -68.21% | -9.83% | -37.47% | 160.27% | 258.47% |
| Cost of Goods Sold | 463K | 479K | 0 | 625K | 0 | 0 | 0 | 0 | 0 | 0 | 613K | 1.51M | 1.46M | 1.45M | 1.22M | 686K | 670K | 577K | 21.92M | 462K |
| COGS % of Revenue | - | - | - | 19.65% | - | - | - | - | - | - | 5.71% | 10.33% | 25.29% | 22.65% | 17.63% | 11.89% | 11.64% | 10.09% | 323.01% | 2.54% |
| Gross Profit | -463K | -479K | 53.81M | 2.56M | 5.39M | 4.12M | 11.61M | 19.88M | 6.47M | 5.43M | 10.12M | 13.09M | 4.31M | 4.96M | 5.7M | 5.08M | 5.09M | 5.14M | -15.14M | 17.69M |
| Gross Margin % | - | - | 100% | 80.35% | 100% | 100% | 100% | 100% | 100% | 100% | 94.29% | 89.67% | 74.71% | 77.35% | 82.37% | 88.11% | 88.36% | 89.91% | -223.01% | 97.45% |
| Gross Profit Growth % | -108.59% | -111.63% | 363.61% | -87.14% | -16.67% | -24.19% | 14.7% | 51.83% | 50.21% | 9.52% | 77.53% | 157.42% | -15.33% | -3.5% | 137.66% | -71.26% | -14.34% | -41.03% | 37.55% | 391.69% |
| Operating Expenses | 48.31M | 41.38M | 39.74M | 43.52M | 47.92M | 45.03M | 44.48M | 49.43M | 48.73M | 40.44M | 35.74M | 36.34M | 34.59M | 35.53M | 35.62M | 30.29M | 30.47M | 27.12M | 4.43M | 22.25M |
| OpEx % of Revenue | - | - | 73.85% | 1368.22% | 888.76% | 1093.68% | 383.26% | 248.69% | 752.99% | 744.69% | 333.07% | 248.92% | 599.97% | 554.14% | 514.78% | 524.81% | 529.12% | 474.51% | 65.32% | 122.55% |
| Selling, General & Admin | 15.23M | 9.76M | 8.92M | 11.34M | 11.48M | 11.09M | 11.22M | 10.77M | 10.66M | 9.11M | 8.6M | 7.67M | 6.55M | 6.43M | 6.88M | 6.55M | 6.14M | 5.49M | 4.43M | 3.17M |
| SG&A % of Revenue | - | - | 16.58% | 356.52% | 212.91% | 269.37% | 96.68% | 54.2% | 164.75% | 167.65% | 80.1% | 52.51% | 113.68% | 100.37% | 99.41% | 113.43% | 106.58% | 96.03% | 65.32% | 17.45% |
| Research & Development | 33.07M | 33.28M | 30.82M | 32.18M | 36.44M | 33.94M | 33.26M | 38.65M | 38.06M | 31.34M | 27.15M | 28.67M | 28.04M | 29.09M | 28.74M | 23.74M | 24.33M | 21.63M | 21.92M | 19.08M |
| R&D % of Revenue | - | - | 57.27% | 1011.69% | 675.85% | 824.31% | 286.58% | 194.49% | 588.24% | 577.04% | 252.97% | 196.4% | 486.28% | 453.77% | 415.38% | 411.38% | 422.54% | 378.48% | 323.01% | 105.1% |
| Other Operating Expenses | 0 | -1000K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1000K | 0 |
| Operating Income | -48.77M | -41.86M | 14.07M | -40.97M | -42.53M | -40.91M | -32.88M | -29.55M | -42.26M | -35.01M | -25.63M | -23.25M | -30.29M | -30.57M | -29.92M | -25.2M | -25.38M | -21.98M | -19.57M | -4.56M |
| Operating Margin % | - | - | 26.15% | -1287.87% | -788.76% | -993.68% | -283.26% | -148.69% | -652.99% | -644.69% | -238.78% | -159.25% | -525.25% | -476.79% | -432.41% | -436.7% | -440.76% | -384.6% | -288.33% | -25.1% |
| Operating Income Growth % | -14.67% | -2.33% | 142.8% | -38.63% | -0.65% | -16.84% | -28.3% | -27.12% | -39.52% | -14.55% | 14.36% | 7.76% | -19.33% | -39.04% | -52.91% | -453.16% | -110.07% | -145.96% | 26.86% | 46.04% |
| EBITDA | -48.31M | -41.38M | 14.63M | -40.34M | -41.91M | -40.29M | -32.26M | -28.92M | -41.63M | -34.4M | -25.01M | -21.74M | -28.83M | -29.11M | -28.7M | -24.52M | -24.71M | -21.41M | -19.34M | -4.09M |
| EBITDA Margin % | - | - | 27.18% | -1268.22% | -777.23% | -978.63% | -277.9% | -145.51% | -643.33% | -633.33% | -233.07% | -148.92% | -499.97% | -454.14% | -414.78% | -424.81% | -429.12% | -374.51% | -285.02% | -22.55% |
| EBITDA Growth % | -15.27% | -2.72% | 145.35% | -39.5% | -0.67% | -17.14% | -28.96% | -33.03% | -44.41% | -18.14% | 12.86% | 11.33% | -16.67% | -36.01% | -48.38% | -498.83% | -112.37% | -151.52% | 27.2% | 50.47% |
| D&A (Non-Cash Add-back) | 463K | 479K | 555K | 625K | 622K | 620K | 622K | 632K | 625K | 617K | 613K | 1.51M | 1.46M | 1.45M | 1.22M | 686K | 670K | 577K | 225K | 462K |
| EBIT | -48.77M | -41.86M | 14.07M | -38.82M | -42.53M | -40.91M | -32.88M | -29.55M | -42.26M | -35.01M | -22.24M | -20.65M | -28.01M | -29.01M | -29.05M | -24.86M | -25.21M | -21.87M | -19.57M | -4.51M |
| Net Interest Income | 2.18M | 1.68M | 1.1M | 1.24M | 1.61M | 1.81M | 1.81M | 2.07M | 2.2M | 2.24M | 1.87M | 1.45M | 1.06M | 591K | 350K | 297K | 218K | 196K | 91K | 104K |
| Interest Income | 2.18M | 1.68M | 1.1M | 1.24M | 1.61M | 1.81M | 1.81M | 2.07M | 2.2M | 2.24M | 1.87M | 1.45M | 1.06M | 591K | 350K | 297K | 218K | 196K | 91K | 104K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 3.26M | 3.06M | 1.8M | 2.15M | 2.69M | 3.29M | 3.77M | 4.07M | 4.38M | 4.3M | 3.39M | 2.6M | 2.28M | 1.56M | 873K | 347K | 171K | 115K | 41K | 42K |
| Pretax Income | -45.51M | -38.8M | 15.87M | -38.82M | -39.84M | -37.62M | -29.11M | -25.49M | -37.87M | -30.72M | -22.24M | -20.65M | -28.01M | -29.01M | -29.05M | -24.86M | -25.21M | -21.87M | -19.53M | -4.51M |
| Pretax Margin % | - | - | 29.5% | -1220.31% | -738.91% | -913.8% | -250.82% | -128.23% | -585.29% | -565.57% | -207.23% | -141.43% | -485.74% | -452.49% | -419.8% | -430.69% | -437.79% | -382.59% | -287.73% | -24.87% |
| Income Tax | 1K | -55K | -10K | 35K | 34K | 49K | 54K | 65K | 40K | 47K | 23K | 64K | 0 | 51K | 0 | 3K | 0 | 177K | 62K | -21K |
| Effective Tax Rate % | -0% | 0.14% | -0.06% | -0.09% | -0.09% | -0.13% | -0.19% | -0.26% | -0.11% | -0.15% | -0.1% | -0.31% | 0% | -0.18% | 0% | -0.01% | 0% | -0.81% | -0.32% | 0.47% |
| Net Income | -45.51M | -38.75M | 15.88M | -38.85M | -39.88M | -37.67M | -29.17M | -25.55M | -37.91M | -30.76M | -22.26M | -20.71M | -28.01M | -29.06M | -29.05M | -24.86M | -25.21M | -22.05M | -19.59M | -4.49M |
| Net Margin % | - | - | 29.52% | -1221.41% | -739.54% | -914.99% | -251.29% | -128.56% | -585.91% | -566.43% | -207.45% | -141.87% | -485.74% | -453.28% | -419.8% | -430.74% | -437.79% | -385.69% | -288.64% | -24.75% |
| Net Income Growth % | -14.14% | -2.86% | 154.46% | -52.06% | -5.17% | -22.45% | -31.01% | -23.38% | -35.37% | -5.86% | 23.36% | 16.69% | -11.11% | -31.82% | -48.29% | -453.26% | -108.23% | -148.71% | 26.91% | 46.46% |
| Net Income (Continuing) | -45.51M | -38.75M | 15.88M | -38.85M | -39.88M | -37.67M | -29.17M | -25.55M | -37.91M | -30.76M | -22.26M | -20.71M | -28.01M | -29.06M | -29.05M | -24.86M | -25.21M | -22.05M | -19.59M | -4.49M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.32 | -0.30 | 0.14 | -0.35 | -0.36 | -0.34 | -0.27 | -0.24 | -0.35 | -0.32 | -0.23 | -0.23 | -0.29 | -0.33 | -0.32 | -0.28 | -0.29 | -0.25 | -0.28 | -0.05 |
| EPS Growth % | 11.11% | 11.76% | 151.85% | -45.83% | -2.86% | -6.25% | -17.39% | -4.35% | -20.69% | 3.03% | 28.13% | 17.86% | 0% | -32% | -14.29% | -444.75% | -107.14% | 40.48% | - | 93.15% |
| EPS (Basic) | -0.32 | -0.30 | 0.14 | -0.35 | -0.36 | -0.34 | -0.27 | -0.24 | -0.35 | -0.32 | -0.23 | -0.23 | -0.29 | -0.33 | -0.32 | -0.28 | -0.29 | -0.25 | -0.28 | -0.05 |
| Diluted Shares Outstanding | 143.58M | 116.17M | 110.97M | 110.54M | 110.3M | 108.68M | 108.51M | 108.31M | 108.17M | 95.8M | 97.03M | 88.35M | 88.19M | 87.97M | 87.89M | 87.84M | 87.67M | 87.57M | 70.16M | 87.47M |
| Basic Shares Outstanding | 143.58M | 116.17M | 110.97M | 110.54M | 110.3M | 108.68M | 108.51M | 108.31M | 108.17M | 95.8M | 97.03M | 88.35M | 88.19M | 87.97M | 87.89M | 87.84M | 87.67M | 87.57M | 70.16M | 87.47M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |